Company / R&D Expense
GE HealthCare R&D Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.3B
FY2025
5-year range
$816.0M / $1.3B
FY2021-FY2025
Trend
-3.9%
vs FY2024
Sector context
#9 of 110
Health Care
What the data says
Among 110 Health Care companies, GE HealthCare is in the top 8% for r&d expense. R&D Expense has fluctuated over the past 5 years, ranging from $816M in FY2023 to $1.3B in FY2024.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 3-year CAGR of +7.1%. Top quartile in the Health Care sector.
Improved from $816M to $1.3B over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +7.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 110This company $1.3B Sector average $298.2M
▼
+322.6% above sector average
Key checks
Key Insights
- 3-year CAGR of +7.1%, indicating consistent growth.
- In FY2025, r&d expense decreased 3.9% year-over-year.
- Ranks #9 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.14 (distress zone, below 1.8 threshold)
- Strong return on equity: 22.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | -3.9% |
| FY2024 | $1.3B | +60.7% |
| FY2023 | $816.0M | -20.5% |
| FY2022 | $1.0B | +25.7% |
| FY2021 | $816.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026